Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.15)
# 1,208
Out of 4,761 analysts
73
Total ratings
32.88%
Success rate
6.5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGON CG Oncology | Reiterates: Buy | $75 | $27.85 | +169.30% | 10 | Jan 10, 2025 | |
| ENGN enGene Holdings | Initiates: Buy | $25 | $6.29 | +297.46% | 1 | Dec 23, 2024 | |
| SRRK Scholar Rock Holding | Maintains: Buy | $40 → $50 | $37.70 | +32.63% | 13 | Nov 26, 2024 | |
| HOWL Werewolf Therapeutics | Reiterates: Buy | $15 | $1.38 | +986.96% | 15 | Nov 19, 2024 | |
| MURA Mural Oncology | Reiterates: Buy | $18 | $4.05 | +344.44% | 3 | Nov 14, 2024 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.41 | +325.53% | 8 | Nov 13, 2024 | |
| IKNA Ikena Oncology | Reiterates: Buy | $4 | $1.39 | +187.77% | 11 | Nov 11, 2024 | |
| DAWN Day One Biopharmaceuticals | Reiterates: Buy | $40 | $12.43 | +221.80% | 12 | Oct 31, 2024 |
CG Oncology
Jan 10, 2025
Reiterates: Buy
Price Target: $75
Current: $27.85
Upside: +169.30%
enGene Holdings
Dec 23, 2024
Initiates: Buy
Price Target: $25
Current: $6.29
Upside: +297.46%
Scholar Rock Holding
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $37.70
Upside: +32.63%
Werewolf Therapeutics
Nov 19, 2024
Reiterates: Buy
Price Target: $15
Current: $1.38
Upside: +986.96%
Mural Oncology
Nov 14, 2024
Reiterates: Buy
Price Target: $18
Current: $4.05
Upside: +344.44%
Erasca
Nov 13, 2024
Reiterates: Buy
Price Target: $6
Current: $1.41
Upside: +325.53%
Ikena Oncology
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.39
Upside: +187.77%
Day One Biopharmaceuticals
Oct 31, 2024
Reiterates: Buy
Price Target: $40
Current: $12.43
Upside: +221.80%